4/A: Biote Corp. Director Corrects Form 4 Filing, Reports Acquisition of 11,045 Deferred Settlement RSUs

Debra L. Morris, a director of Biote Corp., amended a previous Form 4 filing to accurately reflect the acquisition of 11,045 Deferred Settlement Restricted Stock Units (RSUs) on May 21, 2024.

Summary

• This is an amendment to a Form 4 filing by Debra L. Morris, a director of Biote Corp.
• The amendment corrects an error in the original filing made on May 23, 2024.
• The corrected filing reports the acquisition of 11,045 Deferred Settlement RSUs on May 21, 2024.
• These RSUs are fully vested upon grant but will be settled in either calendar year 2025 or upon the director's separation from service.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't contain any particularly positive or negative information, but accuracy in reporting is always a good sign.

Future Outlook

Settlement of the RSUs will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency into the holdings of company insiders.

Stakeholder Impact

• The corrected filing provides accurate information to shareholders regarding the equity holdings of a company director.

Key Dates